Masaki Kato

Summary

Affiliation: Kansai Medical University
Country: Japan

Publications

  1. ncbi request reprint Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Osaka, Japan
    Int Clin Psychopharmacol 20:151-6. 2005
  2. doi request reprint Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Am J Med Genet B Neuropsychiatr Genet 150:115-23. 2009
  3. ncbi request reprint [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment]
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, 10 15 Fumizono cho, Moriguchi, 570 8506, Japan
    Nihon Shinkei Seishin Yakurigaku Zasshi 30:83-92. 2010
  4. doi request reprint Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Eur Neuropsychopharmacol 19:718-25. 2009
  5. ncbi request reprint [5-HT1A gene polymorphisms contributed to antidepressant response in major depression]
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, 10 15 Fumizonocho, Moriguchi 570 8506, Japan
    Nihon Shinkei Seishin Yakurigaku Zasshi 29:23-31. 2009
  6. doi request reprint Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 32:1041-4. 2008
  7. doi request reprint The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
    Masataka Wakeno
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    J Clin Psychopharmacol 28:518-24. 2008
  8. ncbi request reprint ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 32:398-404. 2008
  9. ncbi request reprint Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Japan
    Neuropsychobiology 53:186-95. 2006
  10. doi request reprint A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
    Yoshiteru Takekita
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 40:110-4. 2013

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Osaka, Japan
    Int Clin Psychopharmacol 20:151-6. 2005
    ..These findings suggest that the genetic test may be useful in investigating the efficacy of the two SSRIs, and that normalization by the 5HTTLPR genotypes may lead to improvement of the precision of comparative analysis...
  2. doi request reprint Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Am J Med Genet B Neuropsychiatr Genet 150:115-23. 2009
    ..This finding adds an important information for the pathway of detecting the genetics of antidepressant response even if results must be verified on larger samples...
  3. ncbi request reprint [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment]
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, 10 15 Fumizono cho, Moriguchi, 570 8506, Japan
    Nihon Shinkei Seishin Yakurigaku Zasshi 30:83-92. 2010
    ..The results showed that a pharmacogenetic approach could contribute, at least partially, to predict antidepressant response and personalized medication in depression with consideration of possible confounders...
  4. doi request reprint Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Eur Neuropsychopharmacol 19:718-25. 2009
    ..This finding adds an important piece of information for the pathway of detecting the genetics of antidepressant response...
  5. ncbi request reprint [5-HT1A gene polymorphisms contributed to antidepressant response in major depression]
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, 10 15 Fumizonocho, Moriguchi 570 8506, Japan
    Nihon Shinkei Seishin Yakurigaku Zasshi 29:23-31. 2009
    ..001), week 2 (P < 0.0001), 4 (P = 0.007), and 6 (P = 0.048) as well as response rate (P = 0.0005) and remission rate (P = 0.004). We also pointed out the genotyping mis-definition of rs6295C/G in the previous four papers...
  6. doi request reprint Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 32:1041-4. 2008
    ..The result suggests that C825T variants of GNB3 cannot play a major role as a predictor of treatment response as well as intolerance to SSRIs in Japanese patients with major depression...
  7. doi request reprint The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
    Masataka Wakeno
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    J Clin Psychopharmacol 28:518-24. 2008
    ..In this study, the effect of genetic variants of the ADRA2A gene on the response to selective serotonin reuptake inhibitors (SSRIs)/serotonin norepinephrine reuptake inhibitors (SNRIs) was examined in depressed patients...
  8. ncbi request reprint ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 32:398-404. 2008
    ..Furthermore, the wild variants haplotype (3435C-2677G-1236T) resulted associated with poor response (p=0.006). To our best knowledge, this study is the first suggestion of a possible association of ABCB1 variants with SSRIs response...
  9. ncbi request reprint Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients
    Masaki Kato
    Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Japan
    Neuropsychobiology 53:186-95. 2006
    ..Furthermore, the effects of these polymorphisms varied from one SSRI to another and thus may depend on the characteristics of each SSRI...
  10. doi request reprint A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
    Yoshiteru Takekita
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 40:110-4. 2013
    ..To evaluate the efficacy and safety of aripiprazole and perospirone in Japanese patients with schizophrenia...
  11. doi request reprint Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study
    Gaku Okugawa
    Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
    Psychiatry Clin Neurosci 63:322-8. 2009
    ..To clarify the clinical traits of perospirone in the treatment of schizophrenia, the clinical efficacies and side-effects of perospirone and risperidone were compared in a randomized clinical multicenter trial...
  12. doi request reprint No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression
    Masaki Kato
    Institute of Psychiatry, University of Bologna, Bologna, Italy
    Neuropsychobiology 56:167-71. 2007
    ..In the present study, we examined the possible association of the TPH1 218A/C polymorphism with response to SSRIs in a sample of Japanese patients with major depression...
  13. ncbi request reprint The serotonin transporter gene and effectiveness of SSRIs
    Serretti Alessandro
    Institute of Psychiatry, University of Bologna, Viale Carlo Pepoli 5, 40123, Bologna, Italy
    Expert Rev Neurother 8:111-20. 2008
    ..This article reviews the pharmacogenetic studies published to date, focusing the attention on the SERTPR...
  14. ncbi request reprint Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
    Hajime Sumi
    Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Japan
    Hepatology 37:19-26. 2003
    ....